Benign Prostatic Hyperplasia Treatment Industry - Regional Synopsis
North America Market Forecast
The North America market is projected to hold the largest market share by the end of 2037. The growth of the market can be ascribed to the increasing unhealthy lifestyle, and a higher prevalence of benign prostatic hyperplasia. Furthermore, the presence of major key players, rapidly growing healthcare infrastructure of the region, coupled with the surge in novel drug delivery systems are further projected to influence the growth of the market positively over the forecast period.
The U.S. benign prostatic hyperplasia treatment market is well-established, driven by technological advancements, rising health insurance coverage, and growing preference for minimally invasive procedures. Moreover, as per the data released by the United States Census Bureau, May 2023, about 1 in 6 people in the United States were aged 65 and over in 2020. The older population touched 55.8 million, meaning 16.8% of the total population in the country in the same year. The rapidly widening aging population, coupled with increasing awareness campaigns, is leading to early diagnosis and higher treatment adoption in the U.S.
Asia Pacific Market Forecast
The APAC benign prostatic hyperplasia treatment market is growing due to the region’s aging population, rising healthcare access, and increasing awareness of prostate health. The market is driven by demand for both pharmacological treatments such as alpha-blockers and 5-alpha reductase inhibitors, as well as minimally invasive procedures such as laser therapy. Technological advancements, combined with patient preference for non-invasive solutions, are shaping the market’s evolution across countries such as China, Japan, and India.
India market is expanding due to a growing elderly population, and improved access to urology care. For instance, in May 2024, RG Hospitals announced a groundbreaking advancement in prostate treatment by launching RG NexGen Prostate Treatment- Nano Slim MiPS (Minimally Invasive Prostate Surgery). Government health initiatives, rising medical tourism, and advancements in treatment technologies are further boosting the country’s market growth.
